Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64%
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biogaia AB
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Total Current Liabilities
kr195.7m
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Current Liabilities
kr107.9m
CAGR 3-Years
28%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Current Liabilities
kr724m
CAGR 3-Years
43%
CAGR 5-Years
27%
CAGR 10-Years
20%
Probi AB
STO:PROB
Total Current Liabilities
kr93.2m
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
16%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Current Liabilities
kr13.9B
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
34%
BioArctic AB
STO:BIOA B
Total Current Liabilities
kr125m
CAGR 3-Years
5%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
112.88 SEK
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biogaia AB's Total Current Liabilities?
Total Current Liabilities
195.7m SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Total Current Liabilities amounts to 195.7m SEK.

What is Biogaia AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
6%

Over the last year, the Total Current Liabilities growth was 19%. The average annual Total Current Liabilities growth rates for Biogaia AB have been 13% over the past three years , 6% over the past five years .

Back to Top